Nomura Adjusts Sinopharm Group's Price Target to HK$32.39 Form HK$33.31, Keeps at Buy
MT NewswiresMar 11 05:02 ET
UBS Adjusts Sinopharm Group's Price Target to HK$26 From HK$28, Keeps at Buy
MT NewswiresAug 31, 2022 05:00 ET
No Data